The CJD Foundation (USA) is generously supporting Travel Awards for early-career scientists participating in Prion 2025, which will be held from November 3 to 7, 2025, in Armação dos Búzios, Brazil.

These awards aim to encourage and facilitate the participation of young investigators working on prion diseases and related protein misfolding disorders.

 

Apply Now

Applications are now open. Please submit your materials via the online form:
[Apply for a Travel Award]

 

Timeline

• Applications open: October 2, 2025

• Deadline: October 17, 2025, 23:59 BRT

• Awardee confirmation due: October 31, 2025

 

Required Documents (PDF only)

• Short CV (max 2 pages)

• Accepted abstract (as submitted)

• Proof of registration (receipt)

• Statement of need (200–300 words)

• Optional: Brief supervisor support note (≤1 page)

 

Selection Criteria

Awards will be evaluated on:

• Scientific quality of the accepted abstract

• Career stage fit (final-year PhD or ≤5-year postdoc)

• Justification of need (clarity, plausibility, impact)

• Programmatic balance across topics, institutions, and regions

Being eligible does not guarantee funding; decisions are competitive and subject to available funds.

 

Award Conditions

• Awards support travel costs for in-person participation at Prion 2025 (Nov 3–7, 2025, Búzios, Brazil).

• Recipients must attend and present.

• If a recipient cannot attend, the award may be rescinded and reallocated.

• Further administrative details (payment method, receipts, and deadlines) will be sent directly to awardees.

Note: Exact amounts and the number of awards depend on available funding.

 

FAQ

Who can apply?
Final-year PhD students and postdocs (≤5 years since PhD) who are first authors of accepted abstracts and are fully registered.

Are posters eligible?
Yes—both oral and poster presentations are eligible.

How are awards paid?
Administrative details will be provided to awardees.

Does acceptance guarantee funding?
No. Awards are limited and competitive.

Who funds these awards?
The program is generously supported by the CJD Foundation (USA).